Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;63(9):717-28.
doi: 10.1002/syn.20652.

[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization

Affiliations

[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization

Jinbin Xu et al. Synapse. 2009 Sep.

Abstract

4-(Dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)benzamide (WC-10), a N-phenyl piperazine analog, has been shown to have high affinity and selectivity for dopamine D(3) receptors versus dopamine D(2) receptors (Chu et al. [2005] Bioorg Med Chem 13:77-87). In this study, WC-10 was radiolabeled with tritium (specific activity = 80 Ci/mmol) and [(3)H]WC-10 binding to genetically cloned dopamine D(2L) and D(3) receptors was evaluated in vitro. [(3)H]WC-10 binds with a 66-fold higher affinity to human HEK D(3) than HEK D(2L) receptors, with a dissociation constant (K(d)) of 1.2 nM at HEK D(3) receptors. However, [(3)H]WC-10 binds to rat Sf9 rD(3) receptors with a K(d) of 3.9 nM, a value that is 3-fold lower than binding to human HEK D(3) receptors and 40-fold value higher than binding to rat Sf9 rD(2L) receptors. The K(d) values obtained from saturation binding experiments were consistent with the results determined from kinetic (k(on) and k(off)) studies. The pharmacologic profiles of a series of dopaminergic drugs for inhibiting the binding of [(3)H]WC-10 to D(3) receptors was in agreement with previously reported data. In vitro autoradiography studies of rat and monkey brains show that [(3)H]WC-10 labeled D(3) sites in the striatal region.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Chemical structure of [3H]WC-10
The structure of [3H]WC-10 are shown, detailed synthesis scheme was reported previously (Xu et al., 2009).
Fig. 2
Fig. 2. Saturation analysis of the binding of [3H]raclopride to cloned D2-like dopamine receptors
Direct binding analysis was performed to determine the equilibrium binding affinity of [3H]raclopride for human hD3 and hD2 (A, B) or rat rD3 and rD2 (C, D) receptors. Human receptors were expressed in HEK 293 cells and the rat receptors were expressed in Sf9 cells. Scatchard plots were used to determine the dissociation constants (Kd values). The inset graphs are the Hill plots for determining the Hill coefficient (nH values). Kd and nH are presented as mean values ± S.E.M for n = 3.
Fig. 3
Fig. 3. Saturation analysis of the binding of [3H]WC-10 to rhesus monkey and rat brain
Direct binding analysis was performed to determine the equilibrium binding affinity of [3H]WC-10 binding sites in the rhesus monkey caudate (graph A), putamen (graph B) and rat striatum (graph C). Nonspecific binding was determined from samples which contained 1 uM S(−)-Eticlopride. Scatchard plots were used to determine the dissociation constants (Kd values). The inset graphs are the Hill plots for determining the Hill coefficient (nH values). Kd and nH are presented as mean values ± S.E.M for n = 3.
Fig. 4
Fig. 4. Quantitative autoradiographic analysis of the binding of [3H]WC-10 and [3H]raclopride to rat and rhesus monkey brain
Autoradiograms show neuroanatomical localization of [3H]WC-10 and [3H]raclopride binding sites in rhesus monkey (A, B) and Sprague-Dawley rat (C, D) brain sections. For this study [3H]WC-10 was used at a concentration of 4 nM (A, C) and [3H]raclopride was used at a concentration of 10 nM (B, D). The numbers 1 through 4 in panels A and C designate the following CNS anatomical regions: 1) cortex, 2) primate caudate, 3) primate putamen and 4) rat striatum. Panel E shows autoradiographic image of a [3H]Microscale, which was counted for 24 hours along with the brain sections for the purpose of quantitative analysis.
Fig. 5
Fig. 5. Quantitative calibration of in vitro autoradiography
Calibrated autoradiography standard typical curve obtained by counting a series of tritium standards of a [3H]Microscale, digitalized image was used to analyze the region of interest. This curve was used to convert cpm/mm2 to nCi/mg to quantify autoradiography.
Fig. 6
Fig. 6. Film autoradiography of the binding of [3H]WC-10 to rat brain
Autoradiograms obtained with the traditional film exposure techniques with different exposure time, A. 1 month; B, 3 months. The numbers 1 and 2 designate the following CNS anatomical regions: 1) cortex, 2) rat striatum. For this study [3H]WC-10 was used at a concentration of 4 nM.

References

    1. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL, Gorman JM, Laruelle M. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA. 2000;97:8104–8109. - PMC - PubMed
    1. Ariano MA, Sibley DR. Dopamine receptor distribution in the rat CNS: elucidation using anti-peptide antisera directed against D1A and D3 subtypes. Brain Research. 1994;649:95–110. - PubMed
    1. Boundy VA, Luedtke RR, Gallitano AL, Smith JE, Filtz TM, Kallen RG, Molinoff PB. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies. J Pharmacol Exp Ther. 1993;264:1002–1011. - PubMed
    1. Briand LA, Flagel SB, Seeman P, Robinson TE. Cocaine self-administration produces a persistent increase in dopamine D2 High receptors. Eur Neuropsychopharmacol. 2008;18:551–556. - PMC - PubMed
    1. Camacho-Ochoa M, Walker EL, Evans DL, Piercey MF. Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist. Neurosci Lett. 1995;196:97–100. - PubMed

Publication types

MeSH terms